BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Dalbir S. Sandhu, Randhir Jesudoss. Viral Hepatitis: Chronic Hepatitis C2019; : 109 doi: 10.1007/978-3-030-03757-4_6
2
Evangelista Sagnelli, Margherita Macera, Antonio Russo, Nicola Coppola, Caterina Sagnelli. Epidemiological and etiological variations in hepatocellular carcinomaInfection 2020; 48(1): 7 doi: 10.1007/s15010-019-01345-y
3
Nicola Coppola, Lorenzo Onorato, Marta Panella, Giorgio de Stefano, Nicola Mosca, Carmine Minichini, Vincenzo Messina, Nicoletta Potenza, Mario Starace, Loredana Alessio, Nunzia Farella, Evangelista Sagnelli, Aniello Russo. Correlation Between the Hepatic Expression of Human MicroRNA hsa-miR-125a-5p and the Progression of Fibrosis in Patients With Overt and Occult HBV InfectionFrontiers in Immunology 2018; 9 doi: 10.3389/fimmu.2018.01334
4
Jiaye Liu, Shaohui Qiu, Jingjing Lu, Bingyu Yan, Yi Feng, Li Li, Guomin Zhang, Fuzhen Wang, Peng He, Xin Fang, Zhongyu Hu, Xiaofeng Liang, Aiqiang Xu, Li Zhang. Robust Antibody and Cytokine Response to Hepatitis B Vaccine Among Not-in-Treatment Patients With Chronic Hepatitis C: An Open-Label Control Study in ChinaThe Journal of Infectious Diseases 2017; 216(3): 327 doi: 10.1093/infdis/jix295
5
C. M. Preda, C. P. Popescu, C. Baicus, I. Constantinescu, A. Oproiu, T. Voiosu, M. Diculescu, L. Negreanu, L. Gheorghe, I. Sporea, A. Trifan, E. Ceausu, D. Proca, M. Manuc. Risk of hepatitis B virus reactivation in hepatitis B virus + hepatitis C virus-co-infected patients with compensated liver cirrhosis treated with ombitasvir, paritaprevir/r + dasabuvir + ribavirinJournal of Viral Hepatitis 2018; 25(7): 834 doi: 10.1111/jvh.12872
6
Nicola Coppola, Lorenzo Onorato, Valentina Iodice, Mario Starace, Carmine Minichini, Nunzia Farella, Giulia Liorre, Pietro Filippini, Evangelista Sagnelli, Giorgio de Stefano. Occult HBV infection in HCC and cirrhotic tissue of HBsAg-negative patients: a virological and clinical studyOncotarget 2016; 7(38): 62706 doi: 10.18632/oncotarget.10909
7
Moyra Machado Portilho, Leticia Cancella Nabuco, Cristiane Alves Villela-Nogueira, Carlos Eduardo Brandão-Mello, José Henrique Pilotto, Geane Lopes Flores, Lia Laura Lewis-Ximenez, Elisabeth Lampe, Livia Melo Villar. Detection of occult hepatitis B in serum and oral fluid samplesMemórias do Instituto Oswaldo Cruz 2018; 113(1): 62 doi: 10.1590/0074-02760170071
8
Marcus M Mücke, Lisa I Backus, Victoria T Mücke, Nicola Coppola, Carmen M Preda, Ming-Lun Yeh, Lydia S Y Tang, Pamela S Belperio, Eleanor M Wilson, Ming-Lung Yu, Stefan Zeuzem, Eva Herrmann, Johannes Vermehren. Hepatitis B virus reactivation during direct-acting antiviral therapy for hepatitis C: a systematic review and meta-analysisThe Lancet Gastroenterology & Hepatology 2018; 3(3): 172 doi: 10.1016/S2468-1253(18)30002-5
9
Newaz Hossain, Bharat Puchakayala, Pushpjeet Kanwar, Siddharth Verma, George Abraham, Zhanna Ivanov, Muhammad Obaid Niaz, Smruti R. Mohanty. Risk Factor Analysis Between Newly Screened and Established Hepatitis C in GI and Hepatology ClinicsDigestive Diseases and Sciences 2017; 62(11): 3193 doi: 10.1007/s10620-017-4754-0
10
Caterina Sagnelli, Mariantonietta Pisaturo, Federica Calò, Salvatore Martini, Evangelista Sagnelli, Nicola Coppola. Reactivation of hepatitis B virus infection in patients with hemo-lymphoproliferative diseases, and its preventionWorld Journal of Gastroenterology 2019; 25(26): 3299-3312 doi: 10.3748/wjg.v25.i26.3299
11
Caterina Sagnelli, Evangelista Sagnelli. Towards the worldwide eradication of hepatitis B virus infection: A combination of prophylactic and therapeutic factorsWorld Journal of Clinical Infectious Diseases 2019; 9(2): 11-22 doi: 10.5495/wjcid.v9.i2.11
12
Mohit Mittal, Ke-Qin Hu. Clinical Implications and Management of Chronic Occult Hepatitis B Virus InfectionCurrent Hepatology Reports 2017; 16(2): 90 doi: 10.1007/s11901-017-0339-9
13
C. Trigo, P. E. A. A. do Brasil, M. J. M. Costa, L. de Castro. Occult hepatitis B virus infection: clinical implications in tuberculosis treatmentJournal of Viral Hepatitis 2016; 23(12): 1027 doi: 10.1111/jvh.12583
14
A. Marrone, N. Capoluongo, C. D'Amore, M. Pisaturo, M. Esposito, S. Guastafierro, I. Siniscalchi, M. Macera, A. Boemio, L. Onorato, L. Rinaldi, C. Minichini, L. E. Adinolfi, E. Sagnelli, L. Mastrullo, N. Coppola. Eighteen-month lamivudine prophylaxis on preventing occult hepatitis B virus infection reactivation in patients with haematological malignancies receiving immunosuppression therapyJournal of Viral Hepatitis 2018; 25(2): 198 doi: 10.1111/jvh.12802
15
Yutaka Midorikawa, Tadatoshi Takayama, Hisashi Nakayama, Tokio Higaki, Masamichi Moriguchi, Kyoji Moriya, Tatsuo Kanda, Shunichi Matsuoka, Mitsuhiko Moriyama. Prior hepatitis B virus infection as a co-factor of chronic hepatitis C patient survival after resection of hepatocellular carcinomaBMC Gastroenterology 2019; 19(1) doi: 10.1186/s12876-019-1069-y
16
Agatha S. Rosa, Oscar C. Araujo, Flavia Savassi-Ribas, Carlos A. Fernandes, Henrique S. Coelho, Christian Niel, Cristiane A. Villela-Nogueira, Natalia M. Araujo. Prevalence of occult hepatitis B virus infection and Torque teno virus infection and their association with hepatocellular carcinoma in chronic hepatitis C patientsVirus Research 2017; 242: 166 doi: 10.1016/j.virusres.2017.09.022
17
Nicola Coppola, Carmine Minichini, Mario Starace, Caterina Sagnelli, Evangelista Sagnelli. Clinical impact of the hepatitis C virus mutations in the era of directly acting antiviralsJournal of Medical Virology 2016; 88(10): 1659 doi: 10.1002/jmv.24527
18
Josef Eberle. Hepatitis B — Diagnostisches UpdateMMW - Fortschritte der Medizin 2016; 158(6): 60 doi: 10.1007/s15006-016-8006-6
19
Julio Cesar Rendon, Fabian Cortes-Mancera, Juan Carlos Restrepo-Gutierrez, Sergio Hoyos, Maria-Cristina Navas, Isabelle Chemin. Molecular characterization of occult hepatitis B virus infection in patients with end-stage liver disease in ColombiaPLOS ONE 2017; 12(7): e0180447 doi: 10.1371/journal.pone.0180447
20
Robert G. Gish, Syed Abdul Basit, John Ryan, Altaf Dawood, Ulrike Protzer. Hepatitis B Core Antibody: Role in Clinical Practice in 2020Current Hepatology Reports 2020; 19(3): 254 doi: 10.1007/s11901-020-00522-0
21
Dorota Zarębska-Michaluk, Robert Flisiak, Marta Flisiak-Jackiewicz. Management of hepatitis B and hepatitis C coinfection: an expert reviewExpert Review of Anti-infective Therapy 2020; 18(10): 1033 doi: 10.1080/14787210.2020.1776112
22
Hiroki Koga, Keita Kai, Shinichi Aishima, Atsushi Kawaguchi, Koutaro Yamaji, Takao Ide, Junji Ueda, Hirokazu Noshiro. Occult hepatitis B virus infection and surgical outcomes in non-B, non-C patients with curative resection for hepatocellular carcinomaWorld Journal of Hepatology 2017; 9(35): 1286-1295 doi: 10.4254/wjh.v9.i35.1286
23
E. A. Bazykina, V. B. Turkutyukov, O. E. Trotsenko, V. O. Kotova, L. A. Balakhontseva, L. V. Butakova, L. V. Varnavskaya, V. V. Fomenko, M. A. Chechulina, A. I. Krapivkin, S. V. Zinkovskaya, G. I. Budai, O. A. Yanovich, E. A. Lomakina, Z. I. Lukina. Prevalence and molecular-genetic characteristics of hepatitis B virus in HIV-positive individuals at the Far Eastern Federal DistrictRussian Journal of Infection and Immunity 2019; 9(1): 183 doi: 10.15789/2220-7619-2019-1-183-192
24
Luca Foroghi Biland, Ludovica Ferrari, Vincenzo Malagnino, Elisabetta Teti, Carlotta Cerva, Adele Gentile, Marianna Aragri, Romina Salpini, Valentina Svicher, Massimo Andreoni, Loredana Sarmati. Hepatitis B virus reactivation sustained by a hepatitis B virus surface antigen immune-escape mutant isolate in a patient who was hepatitis B core antibody positive during treatment with sofosbuvir and velpatasvir for hepatitis C virus infection: a case reportJournal of Medical Case Reports 2019; 13(1) doi: 10.1186/s13256-019-2232-3